HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by González-Moles, M.A. Articles by Scully, C. Search for Related Content PubMed PubMed Citation Articles by González-Moles, M.A. Articles by Scully, C.

Vesiculo-erosive Oral Mucosal Disease—Management with Topical Corticosteroids: (2) Protocols, Monitoring of Effects and Adverse Reactions, and the Future

¹ Professor of Oral Medicine, Departamento de Medicina Oral, School of Dentistry, Facultad de Odontología, Universidad de Granada, Campus de Cartuja sn, 18071, Granada, Spain; and
² Dean and Director of Studies and Research, Eastman Dental Institute for Oral Health Care Sciences, University College London, University of London, UK;

^* corresponding author, magonzal{at}ugr.es

Although topical corticosteroids (TCs) are the most widely used drugs in oral medicine, and specifically in the treatment of vesiculo-erosive oral mucosal disease, there are few evidence-based data for the correct use of these drugs. In this review, we outline the most widely used protocols, the most common reasons for treatment failure, and the adverse effects documented in the literature.

KEY WORDS: erosive lesions • oral mucosa • topical corticosteroids

This article has been cited by other articles:

				L.W. Solomon, M.E. Neiders, M.G. Zwick, K.L. Kirkwood, and V. Kumar Autoimmunity to deltaNp63alpha in Chronic Ulcerative Stomatitis J. Dent. Res., September 1, 2007; 86(9): 826 - 831. [Abstract] [Full Text] [PDF]